ArticleOncotarget2018

Optimal time of tumour response evaluation and effectiveness of hypofractionated proton beam therapy for inoperable or recurrent hepatocellular carcinoma.

Tae Hyun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.